|
Files under: News
Posted by: admin @ 03:20 [3. 04. 12]
Germany’s leading venture capital firm High-Tech Gründerfonds and Russian Venture Capital – funded Maxwell Biotech Venture Fund have invested in Hepatera, a Russian startup that develops drugs for the prevention and treatment of liver diseases, and its German partner company MYR GmbH. The new investment will be used for clinical trial program. Founded in September 2011, [...]
|
